Pneumonia as a complication of blood product transfusion in the critically ill: Transfusion-related immunomodulation (TRIM)

Critical Care Medicine

Volumn 34, Issue 5 SUPPL., 2006, Pages

  Vamvakas, Eleftherios C ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Autologous; Filtration; Immunomodulation; Immunosuppression; Infection; Pneumonia; Postoperative; Transfusion: allogeneic; White blood cell reduction; White blood cell reduction filters; White blood cells

Indexed keywords

ALLOGENEIC RESTRICTION; BACTERIAL INFECTION; BLOOD AUTOTRANSFUSION; BLOOD TRANSFUSION; CLINICAL TRIAL; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INFECTION RISK; LEUKOCYTE COUNT; MEDIATOR RELEASE; META ANALYSIS; MULTIPLE ORGAN FAILURE; PNEUMONIA; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECIPIENT; REVIEW; SYSTEMATIC REVIEW; TRANSFUSION RELATED IMMUNOMODULATION;

EID: 33646367895     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000214310.70642.8C     Document Type: Article

References (83)

1. Opelz G, Sengar DP, Mickey MR, et al: Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973; 5:253-259
2. Heiss MN, Mempel W, Delanoff C, et al: Blood transfusion-modulated tumor recurrence: First results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol 1994; 12:1859-1867
3. Jensen LS, Andersen AJ, Christiansen PM, et al: Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992; 79:513-516
4. Heiss MM, Mempel W, Jausch K-W, et al: Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet 1993; 342:1328-1333
5. Jensen LS, Kissmeyer-Nielsen P, Wolff B, et al: Randomized comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet 1996; 348:841-845
6. van de Watering LMG, Hermans J, Houbiers JGA, et al: Beneficial effect of leukocyte depletion of transfused blood on post-operative complications in patients undergoing cardiac surgery: A randomized clinical trial. Circulation 1998; 97:562-568
7. Tartter PI, Mohandas K, Azar P, et al: Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. Am J Surg 1998; 176:462-466
8. Bilgin YM, van de Watering LMG, Eijsman L, et al: Double-blind, randomized controlled trial on the effect of leukocyte-depleted erythrocyte transfusions in cardiac valve surgery. Circulation 2004; 109:2755-2760
9. Peters WR, Fry RD, Fleshman JW, et al: Multiple blood transfusions reduce the recurrence rate of Crohn's disease. Dis Colon Rectum 1989; 32:749-753
10. Hillyer CD, Lankford KV, Roback JD, et al: Transfusion of the HIV-seropositive patient: Immunomodulation, viral reactivation, and limiting exposure to EBV (HHV-4), CMV (HHV-5), and HHV-6, 7, and 8. Transfus Med Rev 1999; 13:1-17
11. Vamvakas EC, Blajchman MA (Eds): Immunomodulatory Effects of Blood Transfusion. Bethesda, MD, AABB Press, 1999
12. Vamvakas EC, Blajchman MA: Deleterious clinical effects of transfusion-associated immunomodulation: Fact or fiction? Blood 2001; 97:1180-1195
13. Vamvakas EC: Possible mechanisms of allogeneic blood transfusion-associated postoperative infection. Transf Med Rev 2002; 16:144-160
14. Bordin JO, Heddle NM, Blajchman MA: Biologic effects of leukocytes present in transfused cellular blood products. Blood 1994; 84:1705-1721
15. Mincheff MS, Meryman HT, Kapoor V, et al: Blood transfusion and immunomodulation: A possible mechanism. Vox Sang 1993; 65:18-24
16. Kao KJ: Induction of humoral immune tolerance to major histocompatibility complex antigens by transfusions of UV-B irradiated leukocytes. Blood 1996; 88:4375-4382
17. Kirkley SA, Cowles J, Pellegrini VD, et al: Blood transfusion and total joint replacement surgery: T helper 2 cytokine secretion and clinical outcome. Transfus Med 1998; 8:195-204
18. Bordin JO, Bardossy L, Blajchman MA: Growth enhancement of established tumors by allogeneic blood transfusion in experimental animals and its amelioration by leukodepletion: The importance of timing of the leukodepletion. Blood 1994; 84:344-348
19. Nielsen HJ: Detrimental effects of perioperative blood transfusion. Br J Surg 1995; 82:582-587
20. Nielsen HJ, Reimert CM, Pedersen AN, et al: Time-dependent, spontaneous release of white cell- and platelet-derived bioactive substances from stored human blood. Transfusion 1996; 36:960-965
21. Ghio M, Contini P, Mazzei C, et al: Soluble HLA Class I, HLA Class II, and Fas ligand in blood components: A possible key to explain the immunomodulatory effects of allogeneic blood transfusion. Blood 1999; 93:1770-1777
22. Magee CC, Sayegh MH: Peptide-mediated immunosuppression. Curr Opin Immunol 1997; 9:669-675
23. Krensky AM, Clayberger C: Structure of HLA molecules and immunosuppressive effects of HLA-derived peptides. Intern Rev Immunol 1996; 13:173-185
24. Puppo F, Contini P, Ghio M, et al: Soluble human MHC class I molecules induce soluble Fas-ligand secretion and trigger apoptosis in activated CD8+ Fas (CD95)+ T lymphocytes. Intern Immunol 2000; 12:195-203
25. Fransen E, Maessen J, Denterner M, et al: Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery. Chest 1999; 116:1233-1239
26. Silliman CC, Voelkel NF, Allard JD, et al: Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J. Clin Invest 1998; 101:1458-1467
27. Sauaia A, Moore FA, Moore EE, et al: Early predictors of postinjury multiple organ failure. Arch Surg 1994; 129:39-45
28. Maetani S, Nishikawa T, Hirakawa A, et al: Role of blood transfusion in organ system failure following major abdominal surgery. Ann Surg 1986; 203:275-281
29. Houbiers JGA, Brand A, van de Watering LMG, et al: Randomized controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet 1994; 344:573-578
30. Titlestad IL, Ebbesen LS, Ainsworth AP, et al: Leukocyte-depletion of blood components does not significantly reduce the risk of infectious complications: Results of a double-blind, randomized study. Int J Colorectal Dis 2001; 16:147-153
31. Wallis JP, Chapman CE, Orr KE, et al: Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery. Transfusion 2002; 42:1127-1134
32. van Hilten JA, van de Watering LMG, van Bockel JH, et al: Effects of transfusion with red cells filtered to remove leukocytes: Randomized controlled trial in patients undergoing major surgery. BMJ 2004; 328:1281-1284
33. Bracey AW, Radovancevick R, Nussimeier NA, et al: Leukocyte-reduced blood in open-heart surgery patients: Effects on outcome. Transfusion 2002; 42(Suppl):5S
34. Klein HG: A wolf in wolfs clothing: Is it time to raise the bounty on the passenger leukocyte? Blood 1992; 80:1865-1868
35. Blajchman MA: Transfusion-associated immunomodulation and universal white cell reduction: Are we putting the cart before the horse? Transfusion 1999; 39:665-670
36. Dzik S, Aubuchon J, Jeffries L, et al: Leukocyte reduction of blood components: Public policy and new technology. Transf Med Rev 2000; 14:34-52
37. Vamvakas EC, Blajchman MA: Universal WBC reduction: The case for and against. Transfusion 2001; 41:691-712
38. Thurer RL, Luban NL, AuBuchon JP, et al: Universal WBC reduction. Transfusion 2002; 42:751-752
39. Corwin HL, AuBuchon JP: Is leukoreduction of blood components for everyone? JAMA 2003; 289:1993-1995
40. Vamvakas EC: Meta-analysis of randomized controlled trials investigating the risk of postoperative infection in association with white blood cell-containing allogeneic blood transfusion: The effects of the type of transfused red blood cell product and surgical setting. Transfus Med Rev 2002; 16:304-314
41. Busch ORC, Hop WCJ, van Papendrecht MAWH, et al: Blood transfusion and prognosis in colorectal cancer. N Engl J Med 1993; 328:1372-1376
42. Newman JH, Bowers M, Murphy J: The clinical advantages of autologous transfusion: A randomized, controlled study after knee replacement. J Bone Joint Surg Br 1997; 79:630-632
43. Farrer A, Spark JI, Scott DJ: Autologous blood transfusion: The benefits for the patient undergoing abdominal aortic aneurysm repair. J Vasc Nurs 1997; 15:111-115
44. Wong JCL, Torella F, Haynes SL, et al: Autologous versus allogeneic transfusion in aortic surgery: A multicenter randomized clinical trial. Ann Surg 2002; 235:145-151
45. Vamvakas E: Meta-analysis of randomized controlled trials comparing the risk of post-operative infection between recipients of allogeneic and autologous blood transfusion. Vox Sang 2002; 83:339-346
46. Cooper H, Hedges LV (Eds): The Handbook of Research Synthesis. New York, Russell Sage Foundation, 1994
47. Boshkov LK, Furnary A, Morris C, et al: Prestorage leukoreduction of red cells in elective cardiac surgery: Results of a double-blind randomized controlled trial. Blood 2004; 104:112a
48. Blumberg N, Heal JM: Effects of transfusion on immune function: Cancer recurrence and infection. Arch Pathol Lab Med 1994; 118:371-379
49. Vamvakas E, Moore SB: Blood transfusions and postoperative septic complications. Transfusion 1994; 34:714-727
50. Vamvakas EC, Carven JH: Transfusion and postoperative pneumonia in coronary artery bypass graft surgery: Effect of the length of storage of transfused red cells. Transfusion 1995; 39:701-710
51. Vamvakas E, Carven JH: Exposure to allogeneic plasma and risk of postoperative pneumonia and/or wound infection in coronary artery bypass graft surgery. Transfusion 2002; 42:107-113
52. Vamvakas E, Carven JH: Allogeneic blood transfusion and postoperative duration of mechanical ventilation. Transfusion 2001; 41:885-892
53. Mynster T, Nielsen HJ: The impact of storage time of transfused blood on postoperative infectious complications in rectal cancer surgery. Scand J Gastroenterol 2000; 35:212-217
54. Offner PLJ, Moore EE, Biff WL, et al: Increased rate of infection associated with transfusion of old blood after severe injury. Arch Surg 2002; 137:711-716
55. Leal-Noval SR, Jara-Lopez I, Garcia-Garmendix JL, et al: Influence of erythrocyte concentrate storage time on postsurgical morbidity in cardiac surgery patients. Anesthesiology 2003; 98:815-822
56. Cart RT: Red cell membrane changes during storage. Transf Med Rev 1988; 2:40-47
57. Wolfe LC: The membrane and the lesion of storage in preserved red cells. Transfusion 1985; 25:185-203
58. Chin-Yee I, Arya N, d'Almeida MS: The red cell storage lesion and its implications for transfusion. Transfus Sci 1997; 18:447-458
59. Groce MA, Fabian TC, Waddle-Smith L, et al: Identification of early predictors for postoperative pneumonia. Am Surg 2001; 67:105-110
60. Shorr AF, Duh M-S, Kelly KM, et al: Red blood cell transfusion and ventilator-associated pneumonia: A potential link? Crit Care Med 2004; 32:666-674
61. Groce MA, Tolley EA, Claridge JA, et al: Transfusions result in pulmonary morbidity and death after a moderate degree of injury. J Trauma 2005; 59:19-23
62. Collier A, Kalish L, Busch M, et al: Leukocyte-reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection. JAMA 2001; 285:1592-1601
63. Baron JF, Gourdin M, Bertrand M, et al: The effect of universal leukodepletion of packed red blood cells on postoperative infections in high-risk patients undergoing abdominal aortic surgery. Anesth Analg 2002; 94:529-537
64. Llewelyn CA, Taylor RS, Todd AA, et al: The effect of universal leukoreduction on postoperative infections and length of stay in elective orthopedic and cardiac surgery. Transfusion 2004; 44:489-500
65. Volkova N, Klapper E, Pepkowitz SH, et al: A case-control study of the impact of WBC reduction on the cost of hospital care for patients undergoing coronary artery bypass graft surgery. Transfusion 2002; 42:1123-1126
66. Hébert PC, Fergusson D, Blajchman MA, et al: Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions. JAMA 2003; 289:1941-1949
67. Fergusson D, Hébert PC, Lee SK, et al: Clinical outcomes following institution of universal leukoreduction of blood transfusions for premature infants. JAMA 2003; 289:1950-1956
68. Vamvakas EC: White-blood-cell containing allogeneic blood transfusion, postoperative infection, and mortality: A meta-analysis of observational, "before-and-after" studies. Vox Sang 2004; 86:111-119
69. Blumberg N, Heal JM, Cowles JW, et al: Leukocyte-reduced transfusions in cardiac surgery: Results of an implementation trial. Am J Clin Pathol 2002; 118:376-381
70. Vamvakas EC: WBC-containing allogeneic blood transfusion and mortality: A meta-analysis of randomized controlled trials. Transfusion 2003; 43:963-973
71. Dzik WH, Anderson JK, O'Neill EM, et al: A prospective, randomized clinical trial of universal WBC reduction. Transfusion 2002; 42:1114-1122
72. Nathens A, Nester T, Nirula R, et al: Effect of leukoreduced transfusion on infection risk in trauma. In: Workshop on Leukocyte Reduction of Blood Components, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, 7/20/2005. Available at http://www.fda.gov/cber/summaries.htm
73. Blumberg N, Zhao H, Messing S, et al: Mis-application of the intention-to-treat principle in clinical trials and meta-analyses of leukoreduced blood transfusions in surgical patients. Blood 2003; 102:562a
74. Fergusson D, Khanna MP, Tinmouth A, et al: Transfusion of leukoreduced red blood cells may decrease postoperative infections: Two meta-analyses of randomized controlled trials. Can J Anaesth 2004; 51:417-24
75. L'Abbé KA, Detsky AS, O'Rourke K: Meta-analysis in clinical research. Ann Intern Med 1987; 107:224-233
76. Stein RA: Meta-analysis from one FDA reviewer's perspective. Proc Biopharmaceut Sect Am Stat Assoc 1988; 2:34-38
77. Fung MK, Rao N, Rice J, et al: Leukoreduction in the setting of open-heart surgery: A prospective cohort-controlled study. Transfusion 2004; 44:30-35
78. Fung M, Moore F, Ridenour M, et al: Clinical outcomes of reverting from leukoreduced to non-leukoreduced blood in cardiac surgery. Transfusion 2004; 44:131A-132A
79. Spiess BD, Royston D, Levy JH, et al: Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. Transfusion 2004; 44:1143-1148
80. Rao SV, Jollis JG, Harrington RA, et al: Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 2004; 292:1555-1562
81. Dzik W: Platelet transfusion and cardiac surgery: A cautionary tale. Transfusion 2004; 44:1132-1134
82. Vamvakas EC: Platelet transfusion and adverse outcomes. Lancet 2004; 264:1736-1738
83. Blumberg N: Deleterious clinical effects of transfusion immunomodulation: Proven beyond a reasonable doubt. Transfusion 2005; 45(Suppl):33S-39S